As of the latest Form 4 filed Jun 23, 2026.
What Axogen Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 39 most recent filings for AXGN.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-23 | 2026-06-19 | JOHNSON JOHN Director | MExercise | +14.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-23 | 2026-06-19 | Wendell Amy McBride Director | MExercise | +14.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-23 | 2026-06-19 | Levine Alan M Director | MExercise | +14.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-23 | 2026-06-19 | Weiler Kathy Johnson Director | MExercise | +14.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-23 | 2026-06-19 | THOMAS PAUL Director | MExercise | +18.9K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-23 | 2026-06-19 | TYNDALL JOSEPH A. Director | MExercise | +14.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-23 | 2026-06-19 | Burke William P. Mr. Director | MExercise | +14.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-12 | 2026-05-08 | Wendell Amy McBride Director | SSale | −1.65K | $42.60 | $70.2K | No | Form 4 ↗ |
| 2026-05-12 | 2026-05-08 | Wendell Amy McBride, Director | MExercise | +1.65K | $14.85 | $24.5K | No | Form 4 ↗ |
| 2026-05-08 | 2026-05-07 | JOHNSON JOHN Director | SSale | −11.1K | $43.26 | $478K | No | Form 4 ↗ |
| 2026-05-08 | 2026-05-07 | JOHNSON JOHN, Director | MExercise | +11.1K | $7.04 | $77.8K | No | Form 4 ↗ |
| 2026-05-08 | 2026-05-07 | Weiler Kathy Johnson Director | SSale | −16.3K | $44.09 | $721K | No | Form 4 ↗ |
| 2026-05-08 | 2026-05-07 | Weiler Kathy Johnson, Director | MExercise | +16.3K | $6.95 | $114K | No | Form 4 ↗ |
| 2026-05-08 | 2026-05-07 | Kemp Jens Chief Marketing Officer | SSale | −4.00K | $43.44 | $174K | No | Form 4 ↗ |
| 2026-05-08 | 2026-05-07 | Hartley Lindsey Marie CFO | SSale | −573.00 | $43.67 | $25.0K | No | Form 4 ↗ |
| 2026-05-08 | 2026-05-07 | Hartley Lindsey Marie, CFO | MExercise | +2.96K | $8.27 | $24.5K | No | Form 4 ↗ |
| 2026-05-08 | 2026-05-07 | Hartley Lindsey Marie, CFO | SSale | −478.00 | $43.67 | $20.9K | No | Form 4 ↗ |
| 2026-05-08 | 2026-05-07 | Hartley Lindsey Marie, CFO | MExercise | +2.50K | $8.20 | $20.5K | No | Form 4 ↗ |
| 2026-05-08 | 2026-05-07 | Quackenbush Doris Sales VP | SSale | −3.88K | $43.51 | $169K | No | Form 4 ↗ |
| 2026-03-18 | 2026-03-16 | DeVinney Erick Wayne Chief Innovation Officer | SSale | −5.22K | $32.84 | $171K | No | Form 4 ↗ |
| 2026-03-18 | 2026-03-16 | DeVinney Erick Wayne, Chief Innovation Officer | MExercise | +11.6K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-18 | 2026-03-16 | DeVinney Erick Wayne, Chief Innovation Officer | FTax | −2.87K | $32.84 | $94.3K | No | Form 4 ↗ |
| 2026-03-18 | 2026-03-16 | DeVinney Erick Wayne, Chief Innovation Officer | MExercise | +6.36K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-18 | 2026-03-16 | Hartley Lindsey Marie CFO | FTax | −1.97K | $32.84 | $64.6K | No | Form 4 ↗ |
| 2026-03-18 | 2026-03-16 | Hartley Lindsey Marie, CFO | MExercise | +5.00K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-18 | 2026-03-16 | Hartley Lindsey Marie, CFO | FTax | −1.57K | $32.84 | $51.7K | No | Form 4 ↗ |
| 2026-03-18 | 2026-03-16 | Hartley Lindsey Marie, CFO | MExercise | +4.00K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-02 | 2026-03-01 | Kemp Jens Chief Marketing Officer | FTax | −2.95K | $30.65 | $90.5K | No | Form 4 ↗ |
| 2026-03-02 | 2026-03-01 | DeVinney Erick Wayne Chief Innovation Officer | FTax | −11.3K | $30.65 | $346K | No | Form 4 ↗ |
| 2026-03-02 | 2026-03-01 | Began Marc A EVP & General Counsel | FTax | −4.43K | $30.65 | $136K | No | Form 4 ↗ |
| 2026-03-02 | 2026-03-01 | Began Marc A, EVP & General Counsel | MExercise | +11.3K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | Kemp Jens Chief Marketing Officer | FTax | −15.4K | $31.90 | $492K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | Kemp Jens, Chief Marketing Officer | AAward | +50.7K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | DeVinney Erick Wayne Chief Innovation Officer | FTax | −10.7K | $31.90 | $341K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | DeVinney Erick Wayne, Chief Innovation Officer | AAward | +33.8K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | Began Marc A EVP & General Counsel | FTax | −8.75K | $31.90 | $279K | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | Began Marc A, EVP & General Counsel | AAward | +33.8K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Hartley Lindsey Marie CFO | FTax | −6.63K | $31.90 | $211K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Hartley Lindsey Marie, CFO | AAward | +17.5K | $0.00 | $0.00 | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also AXGN’s full analysis or the market-wide insider trading feed. The tabs above jump to AXGN’s other SEC data.
Source: SEC Form 4 filings for AXGN, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.